Stocks
Personalis, Inc.PSNL
NASDAQHealthcareBiotechnology$6.72+1.97%
Specializing in advanced genomic sequencing and cancer diagnostics, this company provides precision medicine solutions to healthcare providers and biopharmaceutical firms. Its innovative approach to tumor profiling and immune response monitoring positions it as a key player in the rapidly growing personalized medicine market.
Market Cap: $596.8M52W Range: $2.83 – $11.50
Congressional Interest in Personalis, Inc. (PSNL)
1 member of Congress has disclosed 3 trades in Personalis, Inc. (PSNL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
1
Sells
2
Who in Congress Is Trading PSNL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-05-19 | Brian Mast | sell | $15K – $50K |
| 2020-04-22 | Brian Mast | sell | $1K – $15K |